LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

NeoGenomics Inc

Slēgts

7.41 4.07

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

7.27

Max

7.42

Galvenie mērījumi

By Trading Economics

Ienākumi

-11M

-26M

Pārdošana

-4M

168M

EPS

-0.204

Peļņas marža

-15.427

Darbinieki

2,200

EBITDA

-10M

-6.3M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+84.99% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 28. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-360M

923M

Iepriekšējā atvēršanas cena

3.34

Iepriekšējā slēgšanas cena

7.41

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

NeoGenomics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 4. jūn. 14:53 UTC

Galvenie tirgus virzītāji

BitFuFu Shares Climb on Surge in Bitcoin Production

2025. g. 4. jūn. 14:40 UTC

Galvenie tirgus virzītāji

K Wave Media Shares Triple on Bitcoin Treasury Stock Sale

2025. g. 30. maijs 08:17 UTC

Top Ziņas

Global Markets Mixed Amid Tariff Uncertainty; PCE Inflation Data Eyed

2025. g. 6. jūn. 14:28 UTC

Tirgus saruna

Bitcoin Rises After Above-Forecast U.S. Jobs Data -- Market Talk

2025. g. 4. jūn. 21:26 UTC

Iegādes, apvienošanās, pārņemšana

New MicroStrategy Preferred, a Bitcoin Play, Should Yield 10% or More -- Barrons.com

2025. g. 4. jūn. 11:24 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 4. jūn. 11:24 UTC

Tirgus saruna

Bitcoin ETFs See Outflows -- Market Talk

2025. g. 4. jūn. 09:58 UTC

Tirgus saruna

Bitcoin Eases but Remains Attractive Amid Muted Volatility -- Market Talk

2025. g. 4. jūn. 09:58 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 3. jūn. 10:28 UTC

Tirgus saruna

Bitcoin Rises, Recovering After Recent Falls -- Market Talk

2025. g. 2. jūn. 11:33 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 2. jūn. 11:33 UTC

Tirgus saruna

Bitcoin Falls as Trade Tensions Cause Risk Aversion -- Market Talk

2025. g. 30. maijs 16:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 30. maijs 13:43 UTC

Tirgus saruna

Trump's Immigration Clampdown a Possible Headwind to Digital Assets -- Market Talk

2025. g. 30. maijs 13:43 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 30. maijs 07:18 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 30. maijs 07:18 UTC

Tirgus saruna

Bitcoin Falls on Renewed Tariff Concerns -- Market Talk

2025. g. 29. maijs 07:00 UTC

Tirgus saruna
Peļņas

Bitcoin Rises After Upbeat Nvidia Earnings, Tariff Ruling -- Market Talk

2025. g. 28. maijs 08:21 UTC

Tirgus saruna

Bitcoin Falls Ahead of Nvidia Earnings, Fed Minutes -- Market Talk

2025. g. 27. maijs 20:21 UTC

Top Ziņas

Trump's Media Company to Raise $2.5 Billion to Buy Bitcoin -- 2nd Update

2025. g. 27. maijs 15:44 UTC

Top Ziņas

Trump's Media Company to Raise $2.5 Billion to Buy Bitcoin -- Update

2025. g. 27. maijs 15:36 UTC

Top Ziņas

Trump's Media Company to Raise $2.5 Billion to Buy Bitcoin -- Update

2025. g. 27. maijs 14:44 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

DJT Stock Falls. The Truth Social Parent Is Raising $2.5 Billion to Buy Bitcoin. -- Barrons.com

2025. g. 27. maijs 08:49 UTC

Tirgus saruna

Bitcoin Falls as Trade Uncertainty Dampens Risk Appetite -- Market Talk

2025. g. 26. maijs 09:57 UTC

Tirgus saruna

Bitcoin Rises as U.S. Delay of Big EU Tariffs Supports Risk Appetite -- Market Talk

2025. g. 23. maijs 18:52 UTC

Iegādes, apvienošanās, pārņemšana

DDC Enterprise Issues 254,333 Class A Ordinary Shrs in Exchange for 21 BTC, Valued at About $2.28M in Current Market Price

2025. g. 23. maijs 12:51 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 23. maijs 12:51 UTC

Tirgus saruna

Bitcoin Falls as Trump's EU Tariff Threat Dents Risk Appetite -- Market Talk

2025. g. 23. maijs 07:31 UTC

Tirgus saruna

Bitcoin Eases Slightly After Reaching Fresh Record High -- Market Talk

2025. g. 23. maijs 03:16 UTC

Top Ziņas

Big Banks Explore Venturing Into Crypto World Together With Joint Stablecoin -- WSJ

Salīdzinājums

Cenas izmaiņa

NeoGenomics Inc Prognoze

Cenas mērķis

By TipRanks

84.99% augšup

Prognoze 12 mēnešiem

Vidējais 13.19 USD  84.99%

Augstākais 26 USD

Zemākais 8.5 USD

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi NeoGenomics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

12 ratings

7

Pirkt

5

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

7.7 / 10.27Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.